FGRCX
Price
$32.82
Change
-$0.11 (-0.33%)
Updated
Jun 2 closing price
Net Assets
6.97B
VITSX
Price
$182.22
Change
+$0.44 (+0.24%)
Updated
Jun 2 closing price
Net Assets
2.2T
Interact to see
Advertisement

FGRCX vs VITSX

Header iconFGRCX vs VITSX Comparison
Open Charts FGRCX vs VITSXBanner chart's image
FGRCX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
FGRCX vs. VITSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGRCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.2T vs. FGRCX (6.97B). VITSX pays higher dividends than FGRCX: VITSX (1.01) vs FGRCX (0.03). FGRCX was incepted earlier than VITSX: FGRCX (18 years) vs VITSX (29 years). FGRCX (1.64) is less costly to investors than VITSX (0.03). FGRCX is a more actively managed with annual turnover of: 15.00 vs. VITSX (3.00). FGRCX has a lower initial minimum investment than VITSX: FGRCX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 28.25 vs. FGRCX (26.84). FGRCX return over 5 years is better than : 78.93 vs. VITSX (72.43).
FGRCXVITSXFGRCX / VITSX
Total Expense Ratio1.640.035,467%
Annual Report Gross Expense Ratio1.640.035,467%
Fund Existence18 years29 years-
Gain YTD10.35511.38791%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.97B2.2T0%
Annual Yield % from dividends0.031.013%
Returns for 1 year26.8428.2595%
Returns for 3 years80.9576.04106%
Returns for 5 years78.9372.43109%
Returns for 10 years116.91260.7545%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIOIX13.74N/A
N/A
American Century International Opps Inv
GATCX42.58N/A
N/A
Gabelli Asset C
FWOZX22.08N/A
N/A
Fidelity Advisor Women's Leadership Z
PHPSX28.96N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc
JGMAX27.11N/A
N/A
Janus Henderson Triton A